Tenet Healthcare Corporation

NYSE:THC

Medical - Care Facilities

Healthcare
$271.34 -2.76%

-$5.06 today

Market cap
$21.60B
Beta
1.28
P/E (TTM)
9.1
EPS (TTM)
$19.62
52W Low $146.60High $247.21

Volume 1.57M

Average 1.41M

THC EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Tenet Healthcare CorporationNYSE: THC

EBITDA · Q2 FY2026 · quarter ended Jun 2026

EBITDA growth accelerates

Q2 FY2026 EBITDA of $1.24B rose 17.3% year over year, ahead of the +9.6% change in trailing-twelve-month EBITDA. Sequentially, it fell 20.9% from the prior quarter. Over 3 fiscal years it compounded at +13.4% a year.

Context

  • EBITDA amounted to 21.0% of revenue in FY2025, down 12.3 pp from a year earlier.
  • EBITDA increased in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 14 analysts of $4.28B (-4.5%) for the fiscal year ending Dec 2026, a step up from the -34.9% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.24B-20.9% QoQ
Last fiscal yearDec 2025
$4.48B-34.9% YoY
LTMJun 2026
$5.06B+9.6% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+17.3%-21.0%-38.4 pp
1 year-34.9%-4.5%+30.4 pp
3-year CAGR+13.4%-1.3%-14.7 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
4.48B USD
Year-over-year change
-34.9%
4-year CAGR
+5.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How THC compares with its peers on the latest reported figures

  • THC's LTM Jun 2026 EBITDA of $5.06B is the 2nd highest of the 7 companies compared; the peer median is $1.74B.
  • Its year-over-year change of +9.6% is the 5th highest of 7, against a peer median of +13.2%.
  • EBITDA amounts to 23.2% of revenue for THC, versus a peer median of 20.1%.
THC Competitors Peer median
EBITDA for THC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HCAHCA Healthcare, Inc.LTM Jun 2026$15.84B +10.3%+5.5%20.3%
THCTenet Healthcare CorporationLTM Jun 2026$5.06B +9.6%+13.4%23.2%
CYHCommunity Health Systems, Inc.LTM Mar 2026$4.96B +296.6%+20.0%23.1%
UHSUniversal Health Services, Inc.LTM Jun 2026$2.82B +16.2%+20.3%15.6%
SGRYSurgery Partners, Inc.LTM Sep 2026$667.4M -18.3%+7.1%19.9%
ARDTArdent Health Partners, LLCLTM Mar 2026$505.76M -10.5%-2.2%7.9%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$478.53M +19.3%+7.4%20.5%
Peer median (excluding THC) $1.74B+13.2%+7.3%20.1%

Competitors are the stored peer set for THC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue19.49B19.17B20.55B20.67B21.31B
Cost of Revenue12.22B12.13B12.74B12.46B3.78B
Gross Profit7.27B7.05B7.81B8.21B17.53B
Gross Margin37.3%36.8%38.0%39.7%82.3%
Research & Development00000
Selling, General & Admin412M412M418M8.8B8.71B
Operating Expenses4.4B4.72B5.3B2.25B14.09B
Depreciation & Amortization855M841M870M818M863M
EBITDA3.67B3.08B3.39B6.89B4.48B
EBITDA Margin18.8%16.0%16.5%33.4%21.0%
Operating Income2.87B2.33B2.51B5.96B3.44B
Operating Margin14.7%12.2%12.2%28.8%16.1%
Interest Income00000
Interest Expense923M890M901M826M821M
Other Income / Expenses(983M)(988M)(893M)(708M)(639M)
Income Before Tax1.89B1.35B1.62B5.25B2.8B
Pre-Tax Margin9.7%7.0%7.9%25.4%13.1%
Income Tax Expense411M344M306M1.18B433M
Net Income914M411M611M3.2B1.41B
Net Margin4.7%2.1%3.0%15.5%6.6%
EPS (Basic)8.553.846.0133.0215.61
EPS (Diluted)8.423.795.7132.7015.49
Weighted Avg Shares106.83M106.93M101.64M96.9M90.15M
Weighted Avg Shares (Diluted)108.57M110.52M104.8M97.88M90.83M

Tenet Healthcare Corporation

NYSE:THC

Intrinsic Alpha fair value

Locked

Current Price

$271.34

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.